A new atrial fibrillation (Afib; AF) technology, pulsed field ablation, appears to eliminate abnormal heart rhythms in most patients for at least a year, a researcher reported here.

The FDA has updated its mammography regulations, with the key amendment requiring facilities to provide information to patients regarding the density of their breasts.The amendments, issued under the Mammography Quality Standards Act (MQSA), provide specific language explaining how breast density can influence the accuracy of mammography, and recommend that patients with dense breasts talk to...

Advances in breast cancer management have created opportunities to omit radiotherapy (RT) in selected situations, but women who choose RT should not be considered unreasonable, a radiation oncologist said here.

Prior chest imaging can sometimes be just as predictive of adverse events after surgery as updated imaging, according to new data set to be presented at the annual conference of the American College of Cardiology on March 5. 

Dual source CT scanners can eliminate the need for beta blockers to control heart rates during coronary CTA exams. In turn, this reduces the amount of time it takes to complete such scans, which is of particular interest for chest pain patients in emergency settings, note the authors of a new research paper published March...

New imaging data indicates that the effects of long COVID may begin to dwindle over time, offering hope for those suffering from the long-term ramifications of the virus.

Amy Thompson, a senior analyst at Signify Research, explains what she is seeing in the market for radiology PACS and IT systems. She said the biggest overall, strategic technology trends are wider adoption of enterprise imaging, migration to cloud data storage, adoption of artificial intelligence (AI), streamlining workflow, and implementing structured reporting.

PET/MRI achieves similar or superior results to PET/CT for the detection of pulmonary malignancies, according to new research.

DiA Imaging Analysis, an Israel-based healthcare technology company, has gained U.S. Food and Drug Administration (FDA) clearance for LVivo IQS, a new software solution designed to help users acquire high-quality echocardiography images, regardless of their experience.

Contrast-enhanced spectral mammography (CESM) is a cost-effective alternative to MRI for patients with breast cancer and could save facilities potentially tens of thousands of dollars every year.